185 related articles for article (PubMed ID: 33451037)
21. Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria.
Zhou P; Hong J
Acc Chem Res; 2021 Apr; 54(7):1623-1634. PubMed ID: 33720682
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents.
Ding S; Dai RY; Wang WK; Cao Q; Lan LF; Zhou XL; Yang YS
Bioorg Med Chem Lett; 2018 Jan; 28(2):94-102. PubMed ID: 29233653
[TBL] [Abstract][Full Text] [Related]
23. Identification of apigenin-4'-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies.
Harini M; Kavitha K; Prabakaran V; Krithika A; Dinesh S; Rajalakshmi A; Suresh G; Puvanakrishnan R; Ramesh B
J Mol Model; 2024 Jan; 30(1):22. PubMed ID: 38170229
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
25. Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Daraji DG; Rajani DP; Rajani SD; Pithawala EA; Jayanthi S; Patel HD
Bioorg Med Chem Lett; 2021 Mar; 36():127819. PubMed ID: 33513385
[TBL] [Abstract][Full Text] [Related]
26. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
[TBL] [Abstract][Full Text] [Related]
27. The roles of the prosequence of thermolysin in enzyme inhibition and folding in vitro.
O'Donohue MJ; Beaumont A
J Biol Chem; 1996 Oct; 271(43):26477-81. PubMed ID: 8900115
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for the action of thermolysin.
Tronrud DE; Roderick SL; Matthews BW
Matrix Suppl; 1992; 1():107-11. PubMed ID: 1480010
[TBL] [Abstract][Full Text] [Related]
29. Binding of phosphorus-containing inhibitors to thermolysin studied by the Poisson-Boltzmann method.
Shen J; Wendoloski J
Protein Sci; 1995 Mar; 4(3):373-81. PubMed ID: 7795520
[TBL] [Abstract][Full Text] [Related]
30. Structural evidence for standard-mechanism inhibition in metallopeptidases from a complex poised to resynthesize a peptide bond.
Arolas JL; Botelho TO; Vilcinskas A; Gomis-Rüth FX
Angew Chem Int Ed Engl; 2011 Oct; 50(44):10357-60. PubMed ID: 21915964
[No Abstract] [Full Text] [Related]
31. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
[TBL] [Abstract][Full Text] [Related]
32. Thermolysin and Bacillus subtilis neutral protease. Conformation and stability of two homologous neutral metalloendopeptidases.
Grandi C; Vita C; Dalzoppo D; Fontana A
Int J Pept Protein Res; 1980 Oct; 16(4):327-38. PubMed ID: 6780484
[TBL] [Abstract][Full Text] [Related]
33. Structural comparison suggests that thermolysin and related neutral proteases undergo hinge-bending motion during catalysis.
Holland DR; Tronrud DE; Pley HW; Flaherty KM; Stark W; Jansonius JN; McKay DB; Matthews BW
Biochemistry; 1992 Nov; 31(46):11310-6. PubMed ID: 1445869
[TBL] [Abstract][Full Text] [Related]
34. Inhibition stereochemistry of hydroxamate inhibitors for thermolysin.
Jin Y; Kim DH
Bioorg Med Chem Lett; 1998 Dec; 8(24):3515-8. PubMed ID: 9934463
[TBL] [Abstract][Full Text] [Related]
35. Tethered dimers as NAD synthetase inhibitors with antibacterial activity.
Velu SE; Cristofoli WA; Garcia GJ; Brouillette CG; Pierson MC; Luan CH; DeLucas LJ; Brouillette WJ
J Med Chem; 2003 Jul; 46(15):3371-81. PubMed ID: 12852767
[TBL] [Abstract][Full Text] [Related]
36. A combine approach of chemical synthesis, biological evaluation and structural dynamics studies revealed thiazole substituted arylamine derivatives as potent FabH enzyme inhibitors.
Ahmad H; Ahmad F; Parveen S; Ahmad S; Azam SS; Hassan A
Bioorg Chem; 2020 Dec; 105():104426. PubMed ID: 33161255
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
[TBL] [Abstract][Full Text] [Related]
40. The thermolysin family (M4) of enzymes: therapeutic and biotechnological potential.
Adekoya OA; Sylte I
Chem Biol Drug Des; 2009 Jan; 73(1):7-16. PubMed ID: 19152630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
